المؤلفون: Roy P; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Peer SE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Witte MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Tytgat GAM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Karim-Kos HE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., van Grotel M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van de Ven CP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Mavinkurve-Groothuis AMC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Merks JHM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Clinical Genetics, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Hol JA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Janssens GOR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Radiation Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pathology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Jongmans MCJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Clinical Genetics, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van der Steeg AFW; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Littooij AS; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital (UMCU), Utrecht, The Netherlands., Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Tinteren H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

المصدر: PloS one [PLoS One] 2022 Jan 13; Vol. 17 (1), pp. e0261729. Date of Electronic Publication: 2022 Jan 13 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Kidney Neoplasms/*diagnostic imaging , Kidney Neoplasms/*drug therapy, Adolescent ; Antineoplastic Combined Chemotherapy Protocols ; Child ; Child, Preschool ; Dactinomycin ; Disease-Free Survival ; Humans ; Infant ; Neoplasm Staging ; Netherlands ; Prognosis ; Treatment Outcome ; Vincristine

SCR Protocol: SIOP protocol